<DOC>
	<DOCNO>NCT02789644</DOCNO>
	<brief_summary>A clinical study investigate pharmacokinetics , metabolomics biomarker healthy elderly subject ursodeoxycholic acid administration</brief_summary>
	<brief_title>Clinical Trial Investigate Pharmacokinetics , Metabolomics Biomarker Elderly After UDCA Administration</brief_title>
	<detailed_description>This study randomize , open-label , two-treatment , one-sequence , multiple drug administration design . The purpose study follow ; To investigate pharmacokinetics , metabolomics biomarker healthy elderly subject ursodeoxycholic acid administration</detailed_description>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>Healthy Subjects age 70 84 year A body mass index ( BMI ) range 18.5 kg/m2 29.9 kg/m2 . Good health base complete medical history , physical examination , vital sign , electrocardiography ( ECG ) , clinical laboratory evaluation . Subjects clinically significant disease cardiovascular , respiratory , renal , endocrinological , hematological , gastrointestinal , neurological ( central nervous system ) , psychiatric disorder malignant tumor Subject judge eligible study participation investigator</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Ursodeoxycholic acid</keyword>
	<keyword>Metabolomics/biomarker</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>